IPP Bureau
Aster brings healthcare to the doorsteps with 455 touch points
By IPP Bureau - December 14, 2021
The campaign “Care is Just An Aster Away” was launched along with the unveiling of the new corporate logo on Burj Khalifa on 11th December
Trastuzumab Deruxtecan supplemental New Drug Application for breast cancer submitted in Japan
By IPP Bureau - December 14, 2021
In Japan, breast cancer is the most common cancer in women, with approximately 92,000 cases of breast cancer diagnosed in 2020
Philips set to acquire Vesper Medical
By IPP Bureau - December 14, 2021
Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease
Samsung Biologics expands tie-up with AstraZeneca to include cancer therapy
By IPP Bureau - December 14, 2021
The company will manufacture a cancer immunotherapy product from 2022
Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement
By IPP Bureau - December 14, 2021
Ichnos will receive an upfront payment of Euro 20.8 million as well as additional development and commercial milestone payments and tiered royalties based upon future global sales
ICMR Dibrugarh designs kit to detect Omicron variant in two hours
By IPP Bureau - December 13, 2021
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
Moderna announces positive interim Phase 1 data for mRNA flu vaccine
By IPP Bureau - December 13, 2021
Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed
Govt. to organise Innovation Week to encourage startup ecosystem
By IPP Bureau - December 13, 2021
The proposed week-long event will comprise specific themes - International engagements, market access and incubation support, funding support to startups etc. and will cover the different areas of the innovation lifecycle
Venky’s sets up plant to manufacture veterinary medicinal products
By IPP Bureau - December 13, 2021
The total cost of the project is estimated at Rs 30 crore
Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
By IPP Bureau - December 13, 2021
It is a novel oral NLRP3 inflammasome inhibitor
Nova Nordisk to invest 17 bn Danish kroner to expand capacity in Denmark
By IPP Bureau - December 13, 2021
The investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity
Roche launches next-gen sample sequencing system
By IPP Bureau - December 13, 2021
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare
Landbell and GreenForest solutions announce JV to reduce plastic waste
By IPP Bureau - December 13, 2021
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
KOREA PACK and ICPI to be held in June 2022 in hybrid format
By IPP Bureau - December 13, 2021
KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022
Philips instals 1000 active cath labs in India
By IPP Bureau - December 13, 2021
Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities